Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Anti-N-Methyl-D-Aspartate Receptor Encephalitis × ofatumumab × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 5 Lymphoma 3 Leukemia 3 Burkitt Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Autoimmune Diseases of the Nervous System 1 Anti-N-Methyl-D-Aspartate Receptor Encephalitis 1

Interventions

ofatumumab 1 daratumumab 1 Salpingo-oophorectomy 1 Magnetic Resonance Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06867991 2025-07-15

RADIA

The First People's Hospital of Changzhou

Phase 3 Recruiting

Autoimmune Diseases of the Nervous System, Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡